GE
Gelteq Limited Ordinary Shares
GELS · NASDAQ
$0.52 -5.03% (-$0.03)
1M -25.55%
Market Cap $7.24M
P/E Ratio -
Div. Yield -
ROE 41.59%
Analiza
Raport AI o biznesie, finansach, wycenie, sentymencie, wiadomościach i ryzykach - napisany w kilka minut.
Piotroski F-Score Moderate
4/9Valuation
50 /100
Fair P/S 43.69x
P/B 0.46x
P/E N/A
Growth
31 /100
Declining Rev. growth 3.93%
Book val. growth 8.83%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 100.00%
Net margin 4,011.86%
FCF margin 3,721.12%
Quality
0 /100
Poor ROIC 27.41%
ROE 41.59%
Asset turnover 0.01x
Debt
46 /100
Moderate Debt/Equity 0.27x
Current ratio 0.27x
Int. coverage -2.51x
Stability
33 /100
Unstable Beta -0.39x
Profitable years 0
Rev. volatility N/A
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o GELS
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Nathan Jacob Givoni
Employees
18
Headquarters
Clayton